XML 61 R46.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Details)
1 Months Ended 12 Months Ended
May. 31, 2015
USD ($)
Investor
shares
Oct. 31, 2014
$ / shares
shares
Nov. 30, 2015
USD ($)
Oct. 31, 2015
USD ($)
$ / shares
shares
Sep. 30, 2015
USD ($)
$ / shares
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Apr. 30, 2015
USD ($)
Investor
$ / shares
Feb. 28, 2015
USD ($)
$ / shares
shares
Jun. 30, 2014
USD ($)
Investor
shares
Dec. 31, 2015
USD ($)
ft²
shares
Dec. 31, 2014
USD ($)
shares
Dec. 31, 2013
USD ($)
Related Party Transaction [Line Items]                        
Rent per month                   $ 5,050    
Area of office space (in square feet) | ft²                   900    
Proceeds from issuance of common shares                   $ 34,123,000 $ 44,150,000 $ 25,939,000
Principal and accumulated interest                   $ 255,000 $ 471,000 0
Common shares, issued (in shares) | shares                   94,894,140 83,121,698  
Non-cash stock-based compensation                   $ 11,050,000 $ 4,455,000 $ 3,218,000
BioTime Common Stock [Member]                        
Related Party Transaction [Line Items]                        
Proceeds from issuance of common shares       $ 5,100,000 $ 8,600,000              
Number of shares sold (in shares) | shares   9,431,398   1,600,000 2,607,401       5,000,000 175,000 5,545,160  
Stock price (in dollars per share) | $ / shares   $ 3.12   $ 3.19 $ 3.29              
Number of investors | Investor                 2      
George Karfunkel [Member] | BioTime Common Stock [Member]                        
Related Party Transaction [Line Items]                        
Number of shares sold (in shares) | shares                 4,000,000      
George Karfunkel [Member] | Asterias Warrants [Member]                        
Related Party Transaction [Line Items]                        
Number of shares purchased (in shares) | shares                 4,000,000      
Broadwood Partners LP [Member] | BioTime Common Stock [Member]                        
Related Party Transaction [Line Items]                        
Number of shares sold (in shares) | shares                 1,000,000      
Number of shares purchased (in shares) | shares         2,431,611              
Former Executive [Member]                        
Related Party Transaction [Line Items]                        
Payments of severance compensation     $ 267,000                  
Non-cash stock-based compensation     1,800,000                  
Asterias Biotherapeutics [Member]                        
Related Party Transaction [Line Items]                        
Number of shares purchased (in shares) | shares                 5,000,000      
Asterias Biotherapeutics [Member] | BioTime Common Stock [Member]                        
Related Party Transaction [Line Items]                        
Proceeds from issuance of common shares                 $ 12,500,000      
Number of shares sold (in shares) | shares                 5,000,000      
Number of investors | Investor                 2      
Asterias Biotherapeutics [Member] | Asterias Warrants [Member]                        
Related Party Transaction [Line Items]                        
Proceeds from issuance of common shares                 $ 11,700,000      
Number of shares purchased (in shares) | shares                 1,000,000      
Asterias Biotherapeutics [Member] | Series A Common Stock [Member]                        
Related Party Transaction [Line Items]                        
Proceeds from issuance of common shares               $ 5,500,000        
Number of shares sold (in shares) | shares               1,410,255        
Stock price (in dollars per share) | $ / shares               $ 3.90        
Number of shares purchased (in shares) | shares               1,025,640        
Cell Cure Neurosciences, Ltd. [Member]                        
Related Party Transaction [Line Items]                        
Number of investors | Investor             2          
Stated interest rate             3.00%          
Conversion price (in dollars per share) | $ / shares             $ 20.00          
Estimated fair market value (in dollars per share) | $ / shares             $ 41.00          
Principal and accumulated interest             $ 471,000          
Accrued interest is payable period             3 years          
Effective annual interest rate             23.00%          
Carrying value of convertible notes                   $ 324,000    
Amount of convertible note                   748,000    
Unamortized debt discount                   $ 424,000    
Cell Cure Neurosciences, Ltd. [Member] | Convertible Notes Payable [Member]                        
Related Party Transaction [Line Items]                        
Principal and accumulated interest     $ 66,000       $ 188,000          
Unamortized debt discount             $ 659,000          
OncoCyte [Member] | Subscription Agreements [Member]                        
Related Party Transaction [Line Items]                        
Number of investors | Investor 2                      
OncoCyte [Member] | Second Agreement [Member]                        
Related Party Transaction [Line Items]                        
Non-compete Agreement Term           1 year            
Fair value of warrants           $ 65,400            
OncoCyte [Member] | Second Agreement [Member] | Maximum [Member]                        
Related Party Transaction [Line Items]                        
Investor passive ownership threshold           5.00%            
OncoCyte [Member] | Investors [Member] | OncoCyte Common Stock [Member] | Subscription Agreements [Member]                        
Related Party Transaction [Line Items]                        
Proceeds from issuance of common shares $ 3,300,000                      
Common shares, issued (in shares) | shares 3,000,000                      
OncoCyte [Member] | Investors [Member] | OncoCyte Common Stock [Member] | Second Agreement [Member]                        
Related Party Transaction [Line Items]                        
Pre-offer valuation of rights           $ 40,000,000            
Maximum purchase price of shares of pre-offer           $ 3,000,000            
Number of shares that can be called by warrants (in shares) | shares           3,000,000            
Warrants exercise price (in dollars per share) | $ / shares           $ 0.01            
OncoCyte [Member] | George Karfunkel [Member] | OncoCyte Common Stock [Member] | Subscription Agreements [Member]                        
Related Party Transaction [Line Items]                        
Number of shares sold (in shares) | shares 1,000,000                      
OncoCyte [Member] | George Karfunkel [Member] | OncoCyte Common Stock [Member] | Subscription Agreements [Member] | Minimum [Member]                        
Related Party Transaction [Line Items]                        
Ownership interest rate 5.00%